These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 35034689
21. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Allenbach Y, Benveniste O, Stenzel W, Boyer O. Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664 [Abstract] [Full Text] [Related]
22. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I. J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [Abstract] [Full Text] [Related]
23. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J. J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [Abstract] [Full Text] [Related]
24. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series. Xiong A, Yang G, Song Z, Xiong C, Liu D, Shuai Y, He L, Zhang L, Guo Z, Shuai S. Ther Adv Neurol Disord; 2021 Nov; 14():1756286421998918. PubMed ID: 33786066 [Abstract] [Full Text] [Related]
25. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients. Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y. Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486 [Abstract] [Full Text] [Related]
26. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L. Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398 [Abstract] [Full Text] [Related]
27. [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia]. Itaya K, Inoue M, Iwanami H, Oonaka Y, Jimi T, Ichikawa H. Rinsho Shinkeigaku; 2015 Apr; 55(4):254-8. PubMed ID: 25904255 [Abstract] [Full Text] [Related]
28. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL. Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848 [Abstract] [Full Text] [Related]
29. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493 [Abstract] [Full Text] [Related]
30. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Julien S, Challier I, Malleter M, Jouen F, Drouot L, Boyer O. Antibodies (Basel); 2024 Feb 07; 13(1):. PubMed ID: 38390873 [Abstract] [Full Text] [Related]
31. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y. Autoimmun Rev; 2019 Mar 07; 18(3):223-230. PubMed ID: 30639649 [Abstract] [Full Text] [Related]
32. [Muscle weakness and CK elevation: is it myositis?]. Kernder A, Mucke J, Moldovan AS, Albrecht P, Neuen-Jacob E, Schneider M. Z Rheumatol; 2020 Aug 07; 79(6):578-583. PubMed ID: 32462339 [Abstract] [Full Text] [Related]
33. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Li C, Liu H, Yang L, Liu R, Yin G, Xie Q. J Autoimmun; 2024 Sep 07; 148():103286. PubMed ID: 39033686 [Abstract] [Full Text] [Related]
34. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase. Soares IFZ, Comprido VF, Hsu BRRHS, Alves de Siqueira Carvalho A. BMJ Case Rep; 2020 Oct 08; 13(10):. PubMed ID: 33033004 [Abstract] [Full Text] [Related]
35. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management. Basharat P, Christopher-Stine L. Curr Rheumatol Rep; 2015 Dec 08; 17(12):72. PubMed ID: 26515574 [Abstract] [Full Text] [Related]
36. Unusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy. Moshe-Lilie O, Ghetie D, Banks G, Hansford BG, Chahin N. Neuromuscul Disord; 2022 Feb 08; 32(2):170-175. PubMed ID: 35031192 [Abstract] [Full Text] [Related]
37. [Two cases of statin-induced immune-mediated necrotizing myopathy]. Safi T, Wagner H. Lakartidningen; 2021 Dec 01; 118():. PubMed ID: 34861042 [Abstract] [Full Text] [Related]
38. Therapeutic management of immune-mediated necrotizing myositis. Weeding E, Tiniakou E. Curr Treatm Opt Rheumatol; 2021 Jun 01; 7(2):150-160. PubMed ID: 34422547 [Abstract] [Full Text] [Related]
39. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy. Dandasena T, Ingle V, Singhai A, Saigal S. BMJ Case Rep; 2023 Dec 11; 16(12):. PubMed ID: 38081733 [Abstract] [Full Text] [Related]
40. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease. Nicolau S, Milone M, Tracy JA, Mills JR, Triplett JD, Liewluck T. Muscle Nerve; 2021 Dec 11; 64(6):734-739. PubMed ID: 34617293 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]